AR047466A1 - Compuestos derivados de 3h - imidazo[4,5 - b]piridina con actividad inhibidora de quinasa, composiciones farmacéuticas que los contienen como principio activo y su uso en la fabricacion de un medicamento para el tratatmiento de neoplasmas susceptibles. - Google Patents
Compuestos derivados de 3h - imidazo[4,5 - b]piridina con actividad inhibidora de quinasa, composiciones farmacéuticas que los contienen como principio activo y su uso en la fabricacion de un medicamento para el tratatmiento de neoplasmas susceptibles.Info
- Publication number
- AR047466A1 AR047466A1 ARP050100271A ARP050100271A AR047466A1 AR 047466 A1 AR047466 A1 AR 047466A1 AR P050100271 A ARP050100271 A AR P050100271A AR P050100271 A ARP050100271 A AR P050100271A AR 047466 A1 AR047466 A1 AR 047466A1
- Authority
- AR
- Argentina
- Prior art keywords
- quinasa
- piridine
- imidazo
- manufacture
- contain
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- -1 amino, methyl Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Reivindicacion 1: Un compuesto de formula 1 en la que W es seleccionado de un compuesto del grupo de formulas (2); X es N, o C-R1; R es alquilo C1-7, cicloalquilo C3-7, ( alquileno C1-7)-(cicloalquilo C3-7), -SO2-(alquilo C1-7), o SO2-NR5R6; R1 es hidrogeno, amino, metilo, o -N=CH(NMe)2; R2 es fenilo opcionalmente sustituido con uno o dos sustituyentes seleccionados independientemente entre halo; R3 es hidrogeno, alquilo C1-7, cicloalquilo C3-7, o fenilo opcionalmente sustituido con uno o dos sustituyentes seleccionados independientemente entre halo y trifluorometilo; R4 es hidrogeno o alquilo C1-7; R5 y R6 se seleccionan independientemente entre el grupo constituido por alquilo C1-7; o una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54083004P | 2004-01-30 | 2004-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR047466A1 true AR047466A1 (es) | 2006-01-18 |
Family
ID=34837430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050100271A AR047466A1 (es) | 2004-01-30 | 2005-01-26 | Compuestos derivados de 3h - imidazo[4,5 - b]piridina con actividad inhibidora de quinasa, composiciones farmacéuticas que los contienen como principio activo y su uso en la fabricacion de un medicamento para el tratatmiento de neoplasmas susceptibles. |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7582652B2 (es) |
| EP (1) | EP1713805B1 (es) |
| CN (1) | CN100516064C (es) |
| AR (1) | AR047466A1 (es) |
| AT (1) | ATE433449T1 (es) |
| AU (1) | AU2005210459B2 (es) |
| CA (1) | CA2559128C (es) |
| CY (1) | CY1109234T1 (es) |
| DE (1) | DE602005014848D1 (es) |
| DK (1) | DK1713805T3 (es) |
| DO (1) | DOP2005000010A (es) |
| ES (1) | ES2326819T3 (es) |
| IL (1) | IL178103A (es) |
| MY (1) | MY143516A (es) |
| NZ (1) | NZ549780A (es) |
| PE (1) | PE20050689A1 (es) |
| PL (1) | PL1713805T3 (es) |
| PT (1) | PT1713805E (es) |
| RU (1) | RU2348635C2 (es) |
| SI (1) | SI1713805T1 (es) |
| SV (1) | SV2006002001A (es) |
| TW (1) | TWI332003B (es) |
| UA (1) | UA85505C2 (es) |
| WO (1) | WO2005075478A1 (es) |
| ZA (1) | ZA200607648B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI332003B (en) * | 2004-01-30 | 2010-10-21 | Lilly Co Eli | Kinase inhibitors |
| US7776869B2 (en) * | 2004-10-18 | 2010-08-17 | Amgen Inc. | Heteroaryl-substituted alkyne compounds and method of use |
| EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
| DK2571878T3 (en) | 2010-05-17 | 2019-02-11 | Indian Incozen Therapeutics Pvt Ltd | Hitherto unknown 3,5-DISUBSTITUTED-3H-IMIDAZO [4,5-B] PYRIDINE AND 3,5- DISUBSTITUTED -3H- [1,2,3] TRIAZOL [4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN CHINES |
| AR083868A1 (es) * | 2010-12-03 | 2013-03-27 | Lilly Co Eli | Compuestos de oxazol[5,4-b]piridin-5-ilo |
| BR112014011197A2 (pt) * | 2011-11-11 | 2017-04-25 | Lilly Co Eli | terapia combinada para o câncer ovariano |
| IN2015DN00393A (es) * | 2012-07-23 | 2015-06-19 | Univ Akron | |
| TWI731317B (zh) | 2013-12-10 | 2021-06-21 | 美商健臻公司 | 原肌球蛋白相關之激酶（ｔｒｋ）抑制劑 |
| JP6606183B2 (ja) | 2014-12-18 | 2019-11-13 | ジェンザイム・コーポレーション | トロポミオシン関連キナーゼ（ｔｒｋ）阻害剤の医薬製剤 |
| MA41179A (fr) | 2014-12-19 | 2017-10-24 | Cancer Research Tech Ltd | Composés inhibiteurs de parg |
| TN2017000374A1 (en) | 2015-03-02 | 2019-01-16 | Bristol Myers Squibb Co | TGF-β INHIBITORS |
| RS63581B1 (sr) | 2017-10-05 | 2022-10-31 | Fulcrum Therapeutics Inc | Inhibitori p38 kinaze smanjuju ekspresiju dux4 i nizvodnih gena u cilju lečenja fshd |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| US10899869B2 (en) | 2019-01-24 | 2021-01-26 | The University Of Akron | Glycerol containing polyurethanes and polyurethane nanocomposites |
| TW202112368A (zh) | 2019-06-13 | 2021-04-01 | 荷蘭商法西歐知識產權股份有限公司 | 用於治療有關dux4表現之疾病的抑制劑組合 |
| CR20240391A (es) | 2022-03-23 | 2024-11-05 | Ideaya Biosciences Inc | Compuestos de indazol sustituidos con piperazina como inhibidores de parg |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9300141A (es) | 1992-01-13 | 1994-07-29 | Smithkline Beecham Corp | Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
| DE19503806A1 (de) * | 1994-02-11 | 1995-08-17 | Bernhardt Apparatebau Gmbh Co | Vorrichtung zum Aufblasen eines Behälters oder eines Schwimmkörpers, insbesondere einer Schwimmweste |
| US6426360B1 (en) | 1994-07-28 | 2002-07-30 | G D Searle & Co. | 4,5-substituted imidazolyl compounds for the treatment of inflammation |
| US5620999A (en) | 1994-07-28 | 1997-04-15 | Weier; Richard M. | Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation |
| US5717100A (en) | 1995-10-06 | 1998-02-10 | Merck & Co., Inc. | Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| EP0956018A4 (en) | 1996-08-21 | 2000-01-12 | Smithkline Beecham Corp | IMIDAZOLE COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE |
| US6087496A (en) | 1998-05-22 | 2000-07-11 | G. D. Searle & Co. | Substituted pyrazoles suitable as p38 kinase inhibitors |
| US6180632B1 (en) | 1997-05-28 | 2001-01-30 | Aventis Pharmaceuticals Products Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| WO1999000130A1 (en) | 1997-06-30 | 1999-01-07 | Temple University - Of The Commonwealth System Of Higher Education | Method for treating vulvar vestibulitis |
| AR016294A1 (es) * | 1997-07-02 | 2001-07-04 | Smithkline Beecham Corp | Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion |
| UA62972C2 (en) * | 1997-07-03 | 2004-01-15 | Application of imidazopyrimidins and imidazopyridins for the treatment of neural disorders | |
| JP2001526230A (ja) | 1997-12-19 | 2001-12-18 | スミスクライン・ビーチャム・コーポレイション | ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用 |
| US6207687B1 (en) | 1998-07-31 | 2001-03-27 | Merck & Co., Inc. | Substituted imidazoles having cytokine inhibitory activity |
| US6291457B1 (en) | 1999-07-01 | 2001-09-18 | Merck & Co., Inc. | Compounds having cytokine inhibitory activity |
| US6608072B1 (en) * | 1999-10-27 | 2003-08-19 | Novartis Ag | Thiazole compounds and their pharmaceutical use |
| GB0007405D0 (en) * | 2000-03-27 | 2000-05-17 | Smithkline Beecham Corp | Compounds |
| KR20030080087A (ko) | 2001-03-09 | 2003-10-10 | 화이자 프로덕츠 인코포레이티드 | 항염증제로서의 트리아졸로피리딘 |
| BR0208956A (pt) | 2001-04-16 | 2004-07-13 | Tanabe Seiyaku Co | Abridor de canais de k ativados por cálcio de grande condutância |
| CA2474322A1 (en) | 2002-01-25 | 2003-07-31 | Kylix Pharmaceuticals B.V. | 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2 |
| JP2005538118A (ja) | 2002-08-06 | 2005-12-15 | アストラゼネカ アクチボラグ | Ｔｉｅ２（ｔｅｋ）活性を持つ縮合したピリジン及びピリミジン |
| TWI332003B (en) * | 2004-01-30 | 2010-10-21 | Lilly Co Eli | Kinase inhibitors |
-
2005
- 2005-01-11 TW TW094100682A patent/TWI332003B/zh not_active IP Right Cessation
- 2005-01-25 WO PCT/US2005/000025 patent/WO2005075478A1/en not_active Ceased
- 2005-01-25 ES ES05704878T patent/ES2326819T3/es not_active Expired - Lifetime
- 2005-01-25 CN CNB2005800101425A patent/CN100516064C/zh not_active Expired - Fee Related
- 2005-01-25 UA UAA200610433A patent/UA85505C2/ru unknown
- 2005-01-25 NZ NZ549780A patent/NZ549780A/en not_active IP Right Cessation
- 2005-01-25 PL PL05704878T patent/PL1713805T3/pl unknown
- 2005-01-25 CA CA2559128A patent/CA2559128C/en not_active Expired - Fee Related
- 2005-01-25 SI SI200530740T patent/SI1713805T1/sl unknown
- 2005-01-25 EP EP05704878A patent/EP1713805B1/en not_active Expired - Lifetime
- 2005-01-25 DK DK05704878T patent/DK1713805T3/da active
- 2005-01-25 AU AU2005210459A patent/AU2005210459B2/en not_active Ceased
- 2005-01-25 PT PT05704878T patent/PT1713805E/pt unknown
- 2005-01-25 DE DE602005014848T patent/DE602005014848D1/de not_active Expired - Lifetime
- 2005-01-25 RU RU2006138606/04A patent/RU2348635C2/ru not_active IP Right Cessation
- 2005-01-25 AT AT05704878T patent/ATE433449T1/de active
- 2005-01-25 US US10/597,283 patent/US7582652B2/en not_active Expired - Fee Related
- 2005-01-26 AR ARP050100271A patent/AR047466A1/es not_active Application Discontinuation
- 2005-01-27 MY MYPI20050307A patent/MY143516A/en unknown
- 2005-01-27 DO DO2005000010A patent/DOP2005000010A/es unknown
- 2005-01-27 PE PE2005000103A patent/PE20050689A1/es not_active Application Discontinuation
- 2005-01-28 SV SV2005002001A patent/SV2006002001A/es not_active Application Discontinuation
-
2006
- 2006-09-12 ZA ZA200607648A patent/ZA200607648B/xx unknown
- 2006-09-14 IL IL178103A patent/IL178103A/en not_active IP Right Cessation
-
2009
- 2009-07-14 CY CY20091100735T patent/CY1109234T1/el unknown
- 2009-07-27 US US12/509,886 patent/US20090318443A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL178103A (en) | 2011-04-28 |
| US20090036445A1 (en) | 2009-02-05 |
| CN1938302A (zh) | 2007-03-28 |
| WO2005075478A1 (en) | 2005-08-18 |
| DE602005014848D1 (de) | 2009-07-23 |
| EP1713805B1 (en) | 2009-06-10 |
| EP1713805A1 (en) | 2006-10-25 |
| PE20050689A1 (es) | 2005-09-27 |
| RU2006138606A (ru) | 2008-05-10 |
| US20090318443A1 (en) | 2009-12-24 |
| NZ549780A (en) | 2010-01-29 |
| UA85505C2 (en) | 2009-01-26 |
| SV2006002001A (es) | 2006-02-15 |
| HK1100141A1 (en) | 2007-09-07 |
| CY1109234T1 (el) | 2014-07-02 |
| AU2005210459A1 (en) | 2005-08-18 |
| DOP2005000010A (es) | 2005-11-15 |
| CA2559128C (en) | 2013-04-16 |
| PT1713805E (pt) | 2009-08-20 |
| PL1713805T3 (pl) | 2009-10-30 |
| TWI332003B (en) | 2010-10-21 |
| CN100516064C (zh) | 2009-07-22 |
| MY143516A (en) | 2011-05-31 |
| RU2348635C2 (ru) | 2009-03-10 |
| ATE433449T1 (de) | 2009-06-15 |
| US7582652B2 (en) | 2009-09-01 |
| ZA200607648B (en) | 2008-06-25 |
| ES2326819T3 (es) | 2009-10-20 |
| DK1713805T3 (da) | 2009-08-17 |
| SI1713805T1 (sl) | 2009-10-31 |
| TW200526660A (en) | 2005-08-16 |
| AU2005210459B2 (en) | 2010-10-21 |
| CA2559128A1 (en) | 2005-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR047466A1 (es) | Compuestos derivados de 3h - imidazo[4,5 - b]piridina con actividad inhibidora de quinasa, composiciones farmacéuticas que los contienen como principio activo y su uso en la fabricacion de un medicamento para el tratatmiento de neoplasmas susceptibles. | |
| AR065772A1 (es) | Compuestos de indolobenzazepina para el tratamiento de la hepatitis c. composiciones farmaceuticas. | |
| PE20170003A1 (es) | Compuestos heterociclicos y usos de los mismos | |
| AR053195A1 (es) | Compuestos inhibidores de dipeptidil peptidasa-iv metodos para preparar los mismos y composiciones farmaceuticas que los contienen como un agente activo | |
| AR059957A1 (es) | DERIVADOS DE ESPIROINDOLINONA, MÉTODOS PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE Y SU USO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DEL CÁNCER. | |
| AR068413A2 (es) | Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia | |
| UY28510A1 (es) | Compuestos quimicos | |
| ECSP099371A (es) | INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA | |
| AR046711A1 (es) | 5-7-diaminopirazolo[4,3d]pirimidinas como inhibidores de la pde-5,composiciones farmaceuticas que las contienen y usos en el tratamiento de hipertensiones | |
| BRPI0410714B8 (pt) | derivados de quinazolina macrocíclicos, seu processo de preparação, composição farmacêutica que os compreende e uso | |
| ECSP045253A (es) | Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa | |
| UY32462A (es) | Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644 | |
| AR047076A1 (es) | Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas | |
| ATE438400T1 (de) | Imidazopyridin- und imidazopyrimidin-derivate als antibakterielle mittel | |
| IS8503A (is) | Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar | |
| AR069772A1 (es) | Derivados heterociclicos, una composicion farmaceutica y un juego que los comprenden y su uso en la preparacion de un medicamento para el tratamiento de una infeccion parasitaria. | |
| SE0202133D0 (sv) | Novel compounds | |
| AR067757A1 (es) | Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales. | |
| PE20090816A1 (es) | Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3 | |
| UA100003C2 (ru) | Соединения 1,2,4,5-тетрагидро-3н-бензазепина, способ их получения и фармацевтическая композиция, которая их содержит | |
| AR074608A1 (es) | Derivados de 2-(piperidin-1-il)-4-heterociclil-tiazol-5-carboxilico para infecciones bacterianas | |
| AR043658A1 (es) | Derivados 8-substituidos-6,7,8,9-tetrahidropirimido[1,2-a]pirimidin-4-ona | |
| PE20141352A1 (es) | Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento | |
| AR074604A1 (es) | Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano. | |
| UY31141A1 (es) | Compuestos de piperidina y sus usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed, e.g., due to non-payment of fee |